Armstrong SA - Search Results

1

MLL translocations, histone modifications and leukaemia stem-cell development.

Krivtsov AV, Armstrong SA. Krivtsov AV, et al. Among authors: armstrong sa. Nat Rev Cancer. 2007 Nov;7(11):823-33. doi: 10.1038/nrc2253. Nat Rev Cancer. 2007. PMID: 17957188 Review.

2

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.

Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ. Armstrong SA, et al. Nat Genet. 2002 Jan;30(1):41-7. doi: 10.1038/ng765. Epub 2001 Dec 3. Nat Genet. 2002. PMID: 11731795

3

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ. Armstrong SA, et al. Cancer Cell. 2003 Feb;3(2):173-83. doi: 10.1016/s1535-6108(03)00003-5. Cancer Cell. 2003. PMID: 12620411 Free article.

4

Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.

Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, Look AT. Ferrando AA, et al. Among authors: armstrong sa. Blood. 2003 Jul 1;102(1):262-8. doi: 10.1182/blood-2002-10-3221. Epub 2003 Mar 13. Blood. 2003. PMID: 12637319 Free article.

5

MLL-rearranged leukemias: insights from gene expression profiling.

Armstrong SA, Golub TR, Korsmeyer SJ. Armstrong SA, et al. Semin Hematol. 2003 Oct;40(4):268-73. doi: 10.1016/s0037-1963(03)00196-3. Semin Hematol. 2003. PMID: 14582077 Review.

6

Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.

Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, Korsmeyer SJ. Wang J, et al. Among authors: armstrong sa. EMBO J. 2005 Jan 26;24(2):368-81. doi: 10.1038/sj.emboj.7600521. Epub 2005 Jan 6. EMBO J. 2005. PMID: 15635450 Free PMC article.

7

Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.

Stam RW, den Boer ML, Passier MM, Janka-Schaub GE, Sallan SE, Armstrong SA, Pieters R. Stam RW, et al. Among authors: armstrong sa. Leukemia. 2006 Feb;20(2):264-71. doi: 10.1038/sj.leu.2404074. Leukemia. 2006. PMID: 16357833

8

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, Golub TR, Armstrong SA. Krivtsov AV, et al. Among authors: armstrong sa. Nature. 2006 Aug 17;442(7104):818-22. doi: 10.1038/nature04980. Epub 2006 Jul 16. Nature. 2006. PMID: 16862118

9

Therapeutic implications of leukemia stem cell development.

Stubbs MC, Armstrong SA. Stubbs MC, et al. Among authors: armstrong sa. Clin Cancer Res. 2007 Jun 15;13(12):3439-42. doi: 10.1158/1078-0432.CCR-06-3090. Clin Cancer Res. 2007. PMID: 17575205 Review.

10

MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.

Stubbs MC, Kim YM, Krivtsov AV, Wright RD, Feng Z, Agarwal J, Kung AL, Armstrong SA. Stubbs MC, et al. Among authors: armstrong sa. Leukemia. 2008 Jan;22(1):66-77. doi: 10.1038/sj.leu.2404951. Epub 2007 Sep 13. Leukemia. 2008. PMID: 17851551 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page